247 related articles for article (PubMed ID: 10861053)
1. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
[TBL] [Abstract][Full Text] [Related]
2. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.
Hartemann-Heurtier A; Mars LT; Bercovici N; Desbois S; Cambouris C; Piaggio E; Zappulla J; Saoudi A; Liblau RS
J Immunol; 2004 Jan; 172(2):915-22. PubMed ID: 14707063
[TBL] [Abstract][Full Text] [Related]
3. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.
Nugent CT; Morgan DJ; Biggs JA; Ko A; Pilip IM; Pamer EG; Sherman LA
J Immunol; 2000 Jan; 164(1):191-200. PubMed ID: 10605011
[TBL] [Abstract][Full Text] [Related]
5. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
7. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
8. Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.
Walter U; Franzke A; Sarukhan A; Zober C; von Boehmer H; Buer J; Lechner O
Eur J Immunol; 2000 Apr; 30(4):1224-32. PubMed ID: 10760812
[TBL] [Abstract][Full Text] [Related]
9. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
[TBL] [Abstract][Full Text] [Related]
10. Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice.
Kreuwel HT; Biggs JA; Pilip IM; Pamer EG; Lo D; Sherman LA
J Immunol; 2001 Jul; 167(2):1112-7. PubMed ID: 11441123
[TBL] [Abstract][Full Text] [Related]
11. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
[TBL] [Abstract][Full Text] [Related]
12. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
13. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
Griseri T; Beaudoin L; Novak J; Mars LT; Lepault F; Liblau R; Lehuen A
J Immunol; 2005 Aug; 175(4):2091-101. PubMed ID: 16081775
[TBL] [Abstract][Full Text] [Related]
14. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.
Morgan DJ; Liblau R; Scott B; Fleck S; McDevitt HO; Sarvetnick N; Lo D; Sherman LA
J Immunol; 1996 Aug; 157(3):978-83. PubMed ID: 8757600
[TBL] [Abstract][Full Text] [Related]
15. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens.
Morgan DJ; Kreuwel HT; Sherman LA
J Immunol; 1999 Jul; 163(2):723-7. PubMed ID: 10395663
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
Quinn A; McInerney MF; Sercarz EE
J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
[TBL] [Abstract][Full Text] [Related]
17. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
[TBL] [Abstract][Full Text] [Related]
18. Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.
Garza KM; McKall-Faienza KJ; Otheki T; Zakarian A; Odermatt B; Ohashi PS
Eur J Immunol; 2002 Mar; 32(3):885-94. PubMed ID: 11870633
[TBL] [Abstract][Full Text] [Related]
19. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
[TBL] [Abstract][Full Text] [Related]
20. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
